Genedx Holdings Corp. will attend the 2025 National Society of Genetic Counselors (NSGC) Annual Meeting, taking place in November 2025. At the event, Genedx will showcase advancements in gene-disease discovery, long-read sequencing, and the use of their Infinity rare disease dataset. The company will present research findings in four key sessions, highlighting innovations that improve diagnostic accuracy and expand access to precision medicine.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251106588214) on November 06, 2025, and is solely responsible for the information contained therein.